InsidersTradesSigma
HLB제약 Stock: price and directors' dealings · South Korea · DART (FSS)
Track the HLB제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, HLB제약 has recorded 58 public disclosures. Market capitalisation: €346.7bn. The latest transaction was reported on 4 June 2026 (Other). Among the most active insiders: HLB생명과학. The full history is free.
58
Insider Decl.
0
Thresholds
·
9 ops.
Buy Volume
·
0 ops.
Sell Volume
4Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,760 of 26,211 companies
34.3
score / 100
Value28
Quality41
FCF yld-2.4%
Earn yld1.6%
EV/EBITDA30.7x
ROE-40%
Gross mgn52%
Net mgn2.2%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 4 June 2026
Declarations58 total
25 of 58 declarations